Detalhe da pesquisa
1.
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
Br J Cancer
; 128(11): 2072-2080, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012318
2.
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
Ann Oncol
; 28(10): 2526-2532, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961833
3.
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Ann Oncol
; 27(5): 812-8, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27052658
4.
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.
ESMO Open
; 9(5): 103447, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703431
5.
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.
ESMO Open
; 9(5): 103443, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692082
6.
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
J Neurooncol
; 113(1): 83-92, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23456656
7.
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort.
ESMO Open
; 6(3): 100114, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895695
8.
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
Eur J Cancer
; 158: 181-188, 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689042
9.
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
ESMO Open
; 6(4): 100220, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303929
10.
Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.
Br J Cancer
; 103(6): 772-5, 2010 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736943
11.
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database.
Breast
; 49: 17-24, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675683
12.
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.
Eur J Cancer
; 104: 160-168, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359909
13.
Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188].
Eur J Cancer
; 166: 311-312, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314113
14.
Silent hereditary hematochromatosis as a susceptibility factor of doxorubicin-induced acute cardiac failure.
Ann Oncol
; 21(11): 2293-2294, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937649
15.
[What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?]. / Bilan d'extension des cancers du sein: résultats et conséquences cliniques.
Gynecol Obstet Fertil
; 42(5): 325-30, 2014 May.
Artigo
em Francês
| MEDLINE | ID: mdl-24411340
16.
[Chemotherapy induced emesis: pathophysiology and prevention]. / Nausées et vomissements chimio-induits : physiopathologie, prophylaxie et recommandations.
Bull Cancer
; 97(2): 233-43, 2010 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-20051348
17.
Results and consequence of the systematic staging imaging at the time of the breast cancer diagnosis.
Breast
; 22(4): 555, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23602423